Meridian Bioscience, Inc. (NasdaqGS:VIVO) will look for acquisitions. Chief Executive Officer, Executive Vice President, John P. Kenny commented, "Clearly, we're looking to invest further from an R&D perspective, but also a more programmatic looking into mergers and acquisitions and the opportunities that they may bring for the business over time, that being the case in both Diagnostics and in Life Science."